Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL28992163 | 0.98 | LPAR3 (0.42) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL25380123 | 0.95 | ALDH1A1 (0.45) | TRPV1 | |
| SCHEMBL1254073 | 0.89 | LPAR3 (0.38) | LPAR3LPAR2LPAR1 | |
| SCHEMBL2301357 | 0.76 | LPAR2 (0.44) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL5514820 | 0.76 | LPAR3 (0.44) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL18184028 | 0.76 | LPAR2 (0.50) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL16311960 | 0.76 | LPAR2 (0.50) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL27094088 | 0.75 | LPAR3 (0.46) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL20500069 | 0.74 | LPAR3 (0.49) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL20500071 | 0.74 | LPAR3 (0.49) | LPAR3LPAR2LPAR1FAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023235589-A1 | IONIZABLE LIPIDS, LIPID NANOPARTICLES FOR MRNA DELIVERY AND METHODS OF MAKING THE SAME | UNIVERSITY OF CINCINNATI (US) | 2023-12-07 | — | — | WO | disclosed |
| EP-2506879-A1 | SNALP FORMULATIONS CONTAINING ANTIOXIDANTS | Protiva Biotherapeutics Inc. (CA) | 2012-10-10 | — | — | EP | disclosed |
| WO-2011066651-A1 | SNALP FORMULATIONS CONTAINING ANTIOXIDANTS | PROTIVA BIOTHERAPEUTICS, INC. (CA) | 2011-06-09 | — | — | WO | disclosed |